Abstract
Cryofibrinogens are fibrinogen complexes which precipitate at 4 C. Cryofibrinogenemia is present in 3.4% of oxalated blood samples submitted to the hospital clinical laboratory for complete blood counts. Individuals with cryofibrinogenemia are more likely to have diabetes mellitus than is a random hospital patient. Patients with cryofibrinogenemia are four to five times more likely to have invasive cancer, or a severe thromboembolic episode, or to die, than is a random hospital patient. Patients with cryofibrinogenemia have hyperfibrinogenemia and elevated levels of alpha-1-anti trypsin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.